CR2 and cancer: These lymphoid structures were also positive for follicular markers CD21 and CD23 (Fig. 1f and Extended Data Fig. 2c–e) and contained Bcl6+CD4+ TFH cells (Fig. 1d), which are all characteristics of mature TLS in human cancers, distinct from immature lymphocyte aggregates4,8.